TokenPost·
Ginkgo Bioworks Posts $27.7 Million in Q3 Revenue, Reaffirms 2026 Cash-Burn Outlook
The company recorded a $0.64 GAAP loss per share, $0.22 better than estimates, while revenue exceeded estimates by $6.19 million.
More news
- TokenPostIren Targets $25 Billion in Capital Spending After $25B-$30B Guidance
- TokenPostTrump Blames Midterm Results for Historic Stock Market Setback
- CryptoSlateMEXC sees $126 million outflows as US targets exchange over $16.7 billion in suspected illicit transactions
- TokenPostZiff Davis’ Operating Results Swing to Loss as Revenue Falls 5.6%
- TokenPostTokenized iShares MSCI South Korea ETF (EWY) Falls 1.22% as Price Sits Below Averages
- TokenPostJim Cramer Says AI Stock Sell-Off Differs From Dot-Com Crash